Back to Search Start Over

SEC asks Emcure, Sandoz to submit more data for further approval of ophthalmic injections

Source :
Ingredients South Asia. November 9, 2022
Publication Year :
2022

Abstract

Byline: Gireesh Babu, New Delhi The Expert Committee under the country's drug regulatory organisation has recommended Emcure Pharmaceuticals to conduct pharmacokinetics study and phase III clinical study in Indian population [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Ingredients South Asia
Publication Type :
Periodical
Accession number :
edsgcl.725794461